In addition, upregulated expression of NFE2L3 was significantly associated with poor OS, DFS, and DSS in most tumors, including KIRC, KIRP, LGG, LIHC, MESO, PAAD, GBM, and THYM. The gene discussed is NFE2L3; the disease is pancreatic adenocarcinoma.